Kyle Jenne Net Worth & Insider Trades
Kyle Jenne - Chief Commercial Officer, Akcea Therapeutics, Inc
What is Kyle Jenne's Net Worth?
The current estimated net worth of Akcea Therapeutics, Inc's Chief Commercial Officer, Kyle Jenne, is estimated to be about $22.2K . Kyle Jenne owns about 52,012 units of Akcea Therapeutics, Inc common stock. In the last year at Akcea Therapeutics, Inc, Kyle Jenne has sold an estimated value of $966.22K worth.
What is Kyle Jenne's Past Insider Trading?
Kyle Jenne's largest sale order was 720 units , worth over $13.05K on September 24, 2020. In total, Kyle Jenne has made about 5 transactions over a year of their time at Akcea Therapeutics, Inc. Kyle Jenne usually trades in March and October, with the busiest year in 2020.
Kyle Jenne
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Kyle Jenne's' Mailing Address?
- Mailing address is C/o Akcea Therapeutics, Inc. 22 Boston Wharf Road, 9th Floor Boston MA 02210 MA
What are Akcea Therapeutics, Inc's Past Insider Trades?
Akcea Therapeutics, Inc's most recent insider trade came on October 14, 2020 by Ionis Pharmaceuticals Inc who bought 21,237,715 units worth $385.46M . In the last 3 years, insiders at Akcea Therapeutics, Inc have sold an estimated value of $39.7M and bought an estimated value of $628.66M worth of shares. Insider trading is most common in October, with the busiest year in 2020. The most active traders at the company are Ionis Pharmaceuticals Inc, Jeffrey M. Goldberg, Chief Operating Officer, and Louis Odea, Chief Medical Officer .
AKCEA THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||